SARS-CoV-2 Variants and Vaccines

Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and...

Descripción completa

Detalles Bibliográficos
Autores principales: Krause, Philip R., Fleming, Thomas R., Longini, Ira M., Peto, Richard, Briand, Sylvie, Heymann, David L., Beral, Valerie, Snape, Matthew D., Rees, Helen, Ropero, Alba-Maria, Balicer, Ran D., Cramer, Jakob P., Muñoz-Fontela, César, Gruber, Marion, Gaspar, Rogerio, Singh, Jerome A., Subbarao, Kanta, Van Kerkhove, Maria D., Swaminathan, Soumya, Ryan, Michael J., Henao-Restrepo, Ana-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262623/
https://www.ncbi.nlm.nih.gov/pubmed/34161052
http://dx.doi.org/10.1056/NEJMsr2105280
Descripción
Sumario:Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

Ejemplares similares